Lupron Depot
NDC Package 0074-3154-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lupron Depot is leuprolide is used to treat advanced prostate cancer in men. Marketed by Abbott Laboratories, this product is identified by NDC 0074-3154 and is authorized under FDA application NDA020263.

Identification & Billing

NDC Package Code
0074-3154-01
Package Description
1 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE
Product Code
11-Digit Billing Format
00074315401

Clinical Specifications

Proprietary Name
Lupron Depot
Dosage Form
-
Usage Information
Leuprolide is used to treat advanced prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Leuprolide works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment.

Regulatory & Marketing

Labeler Name
Abbott Laboratories
FDA Application #
NDA020263
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-10-2009
End Marketing Date
02-08-2010
Listing Expiration
02-08-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0074-3154-01 identifies a specific commercial package of 1 syringe in 1 carton / 1 ml in 1 syringe of Lupron Depot, labeled by Abbott Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Abbott Laboratories on December 10, 2009. The current certification is valid through February 08, 2010.

What are the primary indications for this medication?

Leuprolide is used to treat advanced prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Leuprolide works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment.

How is this Abbott Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00074315401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0074-3154-01
11-Digit CMS (5-4-2)
00074-3154-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.